150
AGI – The Anglo-Swedish pharmaceutical group AstraZeneca, manufacturer of the anti-Covid-19 vaccine, doubled its net profit in the first quarter, bringing it to 275 million dollars, thanks to the sales of this serum.
It is the first time that the company reports economic data on its vaccine. AstraZeneca says it will not receive any profits from this front during the pandemic. Sales of the vaccine in Europe were $ 224 million, those in emerging markets $ 43 million and $ 8 million in the rest of the world.
Total turnover, which includes partnership payments, increased 11% to $ 7.32 billion. “We expect the impact of Covid to anticipate an acceleration of performance in the second half of 2021,” said CEO Pascal Soriot.
.